Arrowhead Pharmaceuticals Inc (USD)
ARWR
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range65.70 | 69.00
52-Wk Range10.41 | 73.72
Last Close65.53
Mkt Cap (m)6,271.75
Dividend yield-
ISINUS04280A1007
Volume1,176,818
Exchange VenueNAS

Company Profile

Arrowhead Pharmaceuticals Inc is a biotechnology company. It is engaged in the development of medicine to treat diseases such as hepatitis B, and thrombosis with a genetic origin, primarily divided by the overproduction of one or more proteins.

Key Information
Price/Earning94.97
Price/Book25.64
Price/Sales38.28
P/CF37.34
Rev Growth (3 year avg)921.56
EPS Growth (3 year avg)-
Operating Margin % 36.25
Net Margin %40.27
Return on Equity39.94
Debt/Equity0.02

Legal Documents

Prospectus
en 05/12/2019
Annual Report
en 30/09/2019

Financials

Income Statement
USD201320142015201620172018
Revenue (m)3116
Operating Income (m)-23-51-96-80-37-56
Net Income (m)-31-59-92-82-34-54
Basic EPS-1.30-1.25-1.60-1.34-0.47-0.65
Avg. Diluted Shares Outstanding (m)244757617484
Balance Sheet
USD201320142015201620172018
Current Assets (m)29155103916879
Non Current Assets (m)82829383633
Total Assets (m)37183132128104112
Current Liabilities (m)91216261912
Total Liabilities (m)------
Total Equity (m)27167110968196
Cash Flows
USD201320142015201620172018
Operating Cash Flows (m)-19-35-66-64-24-47
Capital Expenditure (m)-2-2-4-8-1
Figures are quoted in USD unless stated otherwise
1.43 (2.18%)
$
66.96
Last Price